The COVID Xpert Panel Test, offered at DNA Labs UAE for a cost of 1100 AED, is a comprehensive diagnostic tool designed to detect the presence of the SARS-CoV-2 virus, which causes COVID-19. This advanced testing panel not only confirms if an individual is currently infected with the virus but also provides detailed insights into various strains, potentially offering information on variants. Conducted in a state-of-the-art laboratory environment, the test is known for its accuracy and reliability. It plays a crucial role in the ongoing efforts to control and understand the spread of COVID-19, helping healthcare providers and patients make informed decisions regarding treatment and isolation practices.
The "t(12;21)(p13;q22) ETV6-RUNX1 (TEL-AML1) PCR Qualitative Test" is a specialized diagnostic tool used for the detection of the ETV6-RUNX1 gene fusion, which results from a translocation between chromosomes 12 and 21. This genetic anomaly is particularly significant in the context of pediatric acute lymphoblastic leukemia (ALL), where it serves as a common chromosomal alteration. The test employs Polymerase Chain Reaction (PCR) technology to qualitatively identify the presence of this specific gene fusion, offering crucial information for the diagnosis, prognosis, and treatment planning of affected individuals.
Administered by DNA Labs UAE, a leading facility in genetic testing, this test is priced at 1000 AED. DNA Labs UAE is renowned for its state-of-the-art technology and expertise in genetic diagnostics, providing accurate and reliable results. The test's qualitative nature means it aims to detect the presence or absence of the ETV6-RUNX1 fusion gene, rather than quantifying its amount or concentration in the sample. This information is vital for clinicians in making informed decisions regarding the management and therapeutic approach for patients with ALL, particularly in tailoring treatments to individual genetic profiles, thus enhancing the effectiveness of targeted therapies.
The "t(4;11)(q21;q23) MLL-AF4 PCR Qualitative Test" is a specialized diagnostic procedure aimed at identifying the presence of a specific chromosomal translocation between chromosome 4 and chromosome 11, denoted as t(4;11)(q21;q23). This translocation leads to the fusion of the MLL (Mixed Lineage Leukemia) gene on chromosome 11 with the AF4 (ALL Fusion Gene Located on chromosome 4) gene, creating the MLL-AF4 fusion gene. This genetic anomaly is particularly associated with certain types of leukemia, such as acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), and is crucial for diagnosis, prognosis, and determining the treatment strategy.
The test employs Polymerase Chain Reaction (PCR) technology, a highly sensitive and specific method, to qualitatively detect the presence of this fusion gene in a patient's DNA. By amplifying traces of the genetic material, the test can confirm whether the MLL-AF4 fusion gene is present, indicating the likelihood of leukemia characterized by this genetic signature.
Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test assures high standards of accuracy and reliability. The cost of the t(4;11)(q21;q23) MLL-AF4 PCR Qualitative Test is set at 1000 AED. Given the critical information it provides, this test is a valuable tool in the management of leukemia, guiding clinicians in tailoring the most effective treatment plans for their patients.
The T(9;11)(p21-22;q23) MLL-AF9 PCR Qualitative Test is a highly specialized diagnostic procedure designed to detect the presence of the MLL-AF9 gene fusion, which results from a translocation between chromosomes 9 and 11. This genetic anomaly is primarily associated with certain types of leukemia, including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). The test employs Polymerase Chain Reaction (PCR) technology, a sensitive and specific method, to identify the fusion gene's unique DNA sequence, thereby aiding in the diagnosis, prognosis, and management of patients with leukemia.
Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, this test ensures high accuracy and reliability. The cost of the T(9;11)(p21-22;q23) MLL-AF9 PCR Qualitative Test is set at 1000 AED. Given the complexity of the test and the critical information it provides, the price reflects the sophisticated technology and expertise required to conduct such an analysis. By identifying the MLL-AF9 fusion gene, healthcare providers can tailor treatment strategies more effectively, potentially improving patient outcomes in those affected by leukemia associated with this genetic translocation.
The "TB LAMP (Loop Mediated Isothermal Amplification) Qualitative DNA PCR Mycobacterium Tuberculosis Complex Test" is a cutting-edge diagnostic procedure designed to rapidly and accurately detect the presence of Mycobacterium tuberculosis complex, the bacteria responsible for tuberculosis (TB), in a patient's sample. Unlike traditional PCR tests that require cycles of temperature changes, the LAMP method performs DNA amplification at a constant temperature, making the process faster and less resource-intensive. This test is particularly useful in settings where quick and reliable results are crucial for the timely treatment of TB.
Conducted at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test offers a high degree of sensitivity and specificity. The cost of the test is set at 1000 AED, reflecting the advanced technology and expertise involved in providing accurate and reliable results. This test is an essential tool in the fight against tuberculosis, facilitating early detection and the initiation of appropriate treatment strategies to combat this serious infectious disease.
The Varicella Zoster Virus (VZV) Qualitative PCR Test is a highly sensitive diagnostic procedure designed to detect the presence of the VZV DNA in a patient's sample, typically from swabs of skin lesions, cerebrospinal fluid, or blood. This test is crucial for the diagnosis of infections caused by the Varicella Zoster Virus, which is responsible for both chickenpox in first-time infectees and shingles (herpes zoster) in those who have had chickenpox in the past. The PCR (Polymerase Chain Reaction) technique amplifies traces of the virus's DNA, enabling the detection of an active infection even when the viral load is low.
Conducted at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the VZV Qualitative PCR Test offers a reliable and rapid diagnosis essential for initiating timely treatment and managing the spread of the virus. The test is priced at 1000 AED, reflecting the sophisticated technology and expertise involved in conducting the analysis and interpreting the results. By opting for this test at DNA Labs UAE, patients and healthcare providers can expect high-quality service and accurate diagnostic information, which is crucial for effective patient care and management of VZV infections.
The Chlamydia Qualitative PCR Test is a sophisticated diagnostic tool utilized to detect the presence of Chlamydia trachomatis, the bacterium responsible for chlamydia infections, one of the most common sexually transmitted infections (STIs). This test employs Polymerase Chain Reaction (PCR) technology, a highly sensitive and specific method that amplifies the DNA of the bacterium, if present, allowing for its detection even in the absence of symptoms.
Performed at DNA Labs UAE, a leading facility known for its advanced diagnostic services, the Chlamydia Qualitative PCR Test is both reliable and efficient, providing results with a high degree of accuracy. The cost of the test is set at 1000 AED, reflecting the advanced technology and expertise involved in conducting the test. This test is crucial for early detection and treatment of chlamydia, which, if left untreated, can lead to serious health complications. Early diagnosis through the Chlamydia Qualitative PCR Test at DNA Labs UAE can help individuals receive timely treatment, thereby preventing the spread of the infection and reducing the risk of health issues associated with chlamydia.
The Hepatitis-C Virus (HCV) Qualitative PCR Test is a highly sensitive diagnostic tool used to detect the presence of the Hepatitis C virus RNA in a patient's blood. This test is crucial for identifying individuals who are infected with the virus, even in cases where other markers of infection may not be present. Unlike quantitative tests that measure the amount of virus, the qualitative PCR test simply indicates whether the virus is present or not, providing a straightforward "yes" or "no" result.
Performed at DNA Labs UAE, a leading facility in medical diagnostics, this test employs the Polymerase Chain Reaction (PCR) technique. PCR is a sophisticated method that amplifies tiny segments of the virus's RNA to detectable levels, making it one of the most accurate tests available for Hepatitis C. This is particularly important for early diagnosis and for determining the necessity of treatment, as well as for monitoring patients who are undergoing antiviral therapy.
The cost of the Hepatitis-C Virus HCV Qualitative PCR Test at DNA Labs UAE is 1000 AED. While this may represent a significant investment, the accuracy and early detection capabilities of the test can lead to more effective treatment options and a better overall prognosis for individuals infected with HCV. Early diagnosis can prevent the development of more severe liver diseases associated with Hepatitis C, such as cirrhosis and liver cancer, underscoring the value of this test in managing and controlling the spread of the virus.
The Herpes Simplex Virus Type 1 and Type 2 (HSV-1 and HSV-2) Qualitative PCR Test is a highly precise diagnostic procedure offered by DNA Labs UAE, aimed at detecting the presence of either type of the herpes simplex virus (HSV) in the body. This test utilizes Polymerase Chain Reaction (PCR) technology, renowned for its sensitivity and specificity, to identify the genetic material of the virus, allowing for the differentiation between HSV-1, commonly associated with oral herpes, and HSV-2, which is typically linked to genital herpes.
The test is crucial for individuals experiencing symptoms suggestive of herpes infection or for those who have been exposed to the virus and wish to ascertain their status. Early detection through this test can facilitate timely management and reduce the risk of transmission to others. The test process involves the collection of a sample, usually a swab from the affected area or a blood sample, which is then analyzed in the state-of-the-art facilities at DNA Labs UAE.
The cost of the Herpes Simplex Virus Type 1 and Type 2 Qualitative PCR Test at DNA Labs UAE is set at 1000 AED. This investment in health allows individuals to gain valuable insights into their HSV status, empowering them with the information needed to make informed decisions regarding their health and wellbeing.
The Mycobacterium Tuberculosis Qualitative PCR Test is a highly specialized diagnostic tool used to detect the presence of Mycobacterium tuberculosis, the bacterium responsible for tuberculosis (TB). This test employs Polymerase Chain Reaction (PCR) technology, a molecular technique that amplifies the DNA of the bacterium, making it possible to identify an infection even when the bacterial load is low. The qualitative nature of the test means it provides a straightforward positive or negative result, indicating the presence or absence of the bacterium without quantifying its amount.
Performed at DNA Labs UAE, a leading facility in medical diagnostics, this test represents a critical step in the early detection and management of tuberculosis, a disease that remains a significant public health challenge worldwide. The cost of the test is set at 1000 AED, reflecting the sophisticated nature of the technology and the expertise required to accurately interpret the results.
Given the highly contagious nature of tuberculosis and its potential to cause severe health complications, the Mycobacterium Tuberculosis Qualitative PCR Test is a valuable resource in the fight against TB, enabling timely and appropriate treatment interventions.
